Accelerating workflows for Calprotectin and Complement (C4d, TCC) biomarker assays with nanoliter-scale, microfluidic immunoassays

Key Learning Objectives

• Understand the disease states where monitoring of C4d, TCC, and calprotectin are utilized
• Learn about the advantages of microfluidic, nanoliter-scale automated immunoassays for biomarker analysis
• Understand assay performance and advantages over ELISA for the C4d, TCC, and calprotectin Gyrolab immunoassays

Who Should Attend

• Scientists involved in drug development for autoimmune and infectious diseases or inflammatory diseases in academics, biotech, or pharma settings
• Researchers utilizing biomarker immunoassays on human clinical samples
• Bioanalytical groups in pharma or contract research organizations (CROs)